Christine Dolan
Vermögen: 3 Mio $ am 30.06.2026
Vermögen: 3 Mio $ am 30.06.2026
Christine Dolan is EVP & General Manager-Cygnus Technologies at Maravai Lifesciences Holdings, Inc. since 2024.
Former roles include Director-Nuclear Operations & Global Quality at Amersham Health, Director-Nuclear Operations & Global Quality at GE Healthcare, Inc. from 2008 to 2009, and Senior Vice President-Product Development at Catalent, Inc. from 2016 to 2017.
Education includes undergraduate studies at Lenoir-Rhyne University.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 15.05.2026 | 425’318 ( 0.29% ) | 3 Mio $ | 30.06.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| MARAVAI LIFESCIENCES HOLDINGS, INC. | Corporate Officer/Principal | 27.07.2023 |
| Unternehmen | Position | Ende |
|---|---|---|
| CATALENT, INC. | Corporate Officer/Principal | 01.10.2017 |
GE Healthcare, Inc.
GE Healthcare, Inc. Medical SpecialtiesHealth Technology Manufactures and retails diagnostic imaging & medical equipment | Corporate Officer/Principal | 01.09.2009 |
Amersham Health | Corporate Officer/Principal | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 5 |
|---|---|
Lenoir-Rhyne University
Lenoir-Rhyne University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Amersham Health | |
GE Healthcare, Inc.
GE Healthcare, Inc. Medical SpecialtiesHealth Technology Manufactures and retails diagnostic imaging & medical equipment | Health Technology |
Catalent, Inc.
Catalent, Inc. Pharmaceuticals: MajorHealth Technology Provides delivery technologies and development solutions | Health Technology |
Maravai Lifesciences Holdings, Inc.
Maravai Lifesciences Holdings, Inc. BiotechnologyHealth Technology Develops and sells drug therapies, diagnostics and novel vaccines | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen